Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 70

Sort by

Sort Order Select

Journal Articles

Thrombotic Thrombocytopenia Purpura Case Series in Skmc 2016-2017

Mohamed Abu Haleeqa, MBBS, Hanan Al Raeesi, MBBS, Fatima Alkaabi, MBBS

Blood (2019) 134 (Supplement_1): 4799.

https://doi.org/10.1182/blood-2019-126479

Published: 2019

Journal Articles

Kidney Ultrasound Findings in Sickle Cell Anemia According to Kidney Disease and the APOL1 G1/G2 Risk Variants

Sandra Kang, MD, Rishi Patel, MD, Ali Kord Valeshabad, MD, Binal N. Shah, PhD, Rishabh Choudhari, Dallas De La Vara, Jin Han, PharmD, PhD, Michel Gowhari, DO, Shivi Jain, MD, Robert E. Molokie, MD, Karen Xie, MD, James P. Lash, MD, Victor R. Gordeuk, MD, Santosh L. Saraf, MD

Blood (2018) 132 (Supplement 1): 3663.

https://doi.org/10.1182/blood-2018-99-113637

Published: 2018

Journal Articles

The Real-World Frequency of 24-Hour Urine Protein Electrophoresis (UPEP), Serum Free Light Chain (SFLC), and Serum Protein Electrophoresis (SPEP) Testing in Patients with Multiple Myeloma (MM)

Rebekah B. Foster, Nicole G. Lipitz, Aracelis Z. Torres, Kenneth R. Carson, MD PhD

Blood (2018) 132 (Supplement 1): 3536.

https://doi.org/10.1182/blood-2018-99-113508

Published: 2018

Journal Articles

Urine Cultures at the Onset of Febrile Neutropenia (FN) in Patients with Haematological Malignancies Rarely Impact Antibiotic Management in the Absence of Urinary Symptoms

Sam Grigg, BSc, Patrick Date, BSc, Eliza A Hawkes, FRACP, MBBS, Douglas Johnson, MBBS, PhD FRACP, Zoe Loh, MBBS, Ortis Estacio, MD, Andrew P Grigg, MBBS, MD FRACP, FRCPA

Blood (2017) 130 (Supplement 1): 3435.

https://doi.org/10.1182/blood.V130.Suppl_1.3435.3435

Published: 2017

Journal Articles

Comparison of Residual Neoplastic Plasma Cell Number Using Multicolor Flow Cytometry and Various Stages of International Myeloma Working Group-Defined Responses in Patients with Multiple Myeloma

Kentaro Narita, MD, Hiroyuki Takamatsu, MD PhD, Hiroki Kobayashi, MD, Yoshiaki Abe, Masami Takeuchi, MD, Kosei Matsue, MD PhD

Blood (2017) 130 (Supplement 1): 5359.

https://doi.org/10.1182/blood.V130.Suppl_1.5359.5359

Published: 2017

Journal Articles

A Case of Immunotactoid Glomerulopathy (ITG) Associated with Monoclonal B-Cell Lymphocytosis (MBL) with Chronic Lymphocytic Leukemia (CLL) Phenotype Treated with Obinutuzumab

Nino Aleksidze, MD, Michael B Stokes, MD, Alan P Skarbnik, MD

Blood (2017) 130 (Supplement 1): 5324.

https://doi.org/10.1182/blood.V130.Suppl_1.5324.5324

Published: 2017

Journal Articles

Ambulatory Hypertension in a Pediatric Cohort of Sickle Cell Disease

Divya G Moodalbail, MD, Bonita Falkner, MD

Blood (2017) 130 (Supplement 1): 984.

https://doi.org/10.1182/blood.V130.Suppl_1.984.984

Published: 2017

Journal Articles

Dasatinib Induced Reversible Nephrotic Range Proteinuria Occurs More Frequently Compared to Other Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia

Ali Alahmari, MD, Jeffrey H. Lipton, MD PhD, Dennis Kim, MD

Blood (2017) 130 (Supplement 1): 2880.

https://doi.org/10.1182/blood.V130.Suppl_1.2880.2880

Published: 2017

Journal Articles

Phase II, Multiple-Dose Study of Anti-FcRn Antibody, Rozanolixizumab (UCB7665), in Patients with Primary Immune Thrombocytopenia: Interim Analysis

Tadeusz Robak, Isidro Jarque, Vasile Musteata, Peter Kiessling, Ute Massow, James Higginson, Rose Snipes, Stephen Jolles

Blood (2017) 130 (Supplement 1): 15.

https://doi.org/10.1182/blood.V130.Suppl_1.15.15

Published: 2017

Journal Articles

SYNT001: A Humanized IgG4 Monoclonal Antibody That Disrupts the Interaction of FcRn and IgG for the Treatment of IgG-Mediated Autoimmune Diseases

Laurence Blumberg, MD, John E Humphries, MD, Kenneth C Lasseter, MD, Richard S Blumberg, MD

Blood (2017) 130 (Supplement 1): 3483.

https://doi.org/10.1182/blood.V130.Suppl_1.3483.3483

Published: 2017

Journal Articles

Impact of Normalized Free Light Chain Ratio for Assessment of Monoclonal Protein in Patients with Light Chain Only and Oligosecretory Myeloma

Kentaro Narita, MD, Yoshiaki Usui, MD, Yoshiaki Abe, MD, Masami Takeuchi, MD, Kosei Matsue, MD PhD

Blood (2016) 128 (22): 2074.

https://doi.org/10.1182/blood.V128.22.2074.2074

Published: 2016

Journal Articles

Novel Mutation in CD46 in a Child with Atypical Hemolytic Uremic Syndrome (HUS) Characterized By Profound Thrombocytopenia and Anemia

Catherine Joseph, MD, Pritchard Aaron, MD, Nasim Pourtabatabaei, MD, Stuart S. Winter, MD, Craig Wong, MD MPH, Amy Staples, MD MPH, John Brandt, MD MPH

Blood (2016) 128 (22): 4884.

https://doi.org/10.1182/blood.V128.22.4884.4884

Published: 2016

Journal Articles

Nonclinical Safety of SHP 826 (BAX 826), a Next Generation Extended Half-Life Recombinant Factor VIII Product

Veronika Ehrlich, Peter Leidenmuehler, Barbara Dietrich, Gerald Hoebarth, Tanja Ruthsatz, Peter L. Turecek, PhD, Martin Wolfsegger, Cstat (RSS), Alfred Weber, Herbert Gritsch, Werner Hoellriegl, Marietta Turecek

Blood (2016) 128 (22): 4977.

https://doi.org/10.1182/blood.V128.22.4977.4977

Published: 2016

Journal Articles

Establishing Sickle Cell Diagnostics and Characterizing a Pediatric Sickle Cell Disease Cohort in Malawi

Jonathan Brett Heimlich, Godwin Chipoka, MBBS, Portia Kamthunzi, Yuri D. Fedoriw, MD, Nigel S. Key, MB, ChB, Kenneth I. Ataga, MD, Satish Gopal

Blood (2015) 126 (23): 2070.

https://doi.org/10.1182/blood.V126.23.2070.2070

Published: 2015

Journal Articles

Hematuria Is Not a Risk Factor for the Hypertension of Hemophilia

Haowei (Linda) Sun, MD, Ming Yang, PhD, Afrah S Sait, MD, Annette Von Drygalski, MD PharmD, Shannon Jackson

Blood (2015) 126 (23): 2301.

https://doi.org/10.1182/blood.V126.23.2301.2301

Published: 2015

Journal Articles

Multidisciplinary Evaluation Improves Efficacy and Safety of Iron Chelation Therapy with Deferasirox in MDS Elderly Patients

Blood (2015) 126 (23): 4558.

https://doi.org/10.1182/blood.V126.23.4558.4558

Published: 2015

Journal Articles

Screening for Occult Malignancy Following First Unprovoked VTE: A Single Centre Experience

Ruochen Li, BA (Hons), MB BChir, Cara Doyle, BN (Hons) RGN, Lara N Roberts, MD, Kathryn Jane Lang, MRCP, MBBS, Emma Gee, Julia Czuprynska, MBBS, Raj K Patel, MD, Roopen Arya, PhD

Blood (2015) 126 (23): 3550.

https://doi.org/10.1182/blood.V126.23.3550.3550

Published: 2015

Journal Articles

Transition of Intensive Chemotherapy for Acute Lymphoblastic Leukemia (ALL) to the Outpatient Setting: Analysis of Safety and Cost Savings

Timothy E. Kubal, MD MBA, Christopher Rodriguez Salamanca, PA, Julio C Chavez, MD, Bijal D. Shah, MD, Rami S. Komrokji, MD, Viet Q. Ho, PharmD, RPh, BCOP, Jeffrey E Lancet, MD

Blood (2015) 126 (23): 5604.

https://doi.org/10.1182/blood.V126.23.5604.5604

Published: 2015

Journal Articles

Prognostic Value of Sequencing-Based Minimal Residual Disease Detection in Patients with Multiple Myeloma Who Underwent Autologous Stem Cell Transplantation

Hiroyuki Takamatsu, Ryoichi Murata, MD, Jianbiao Zheng, Martin Moorhead, Naoki Takezako, Shigeki Ito, MD PhD, Toshihiro Miyamoto, MD PhD, Kenji Yokoyama, Kosei Matsue, MD PhD, Tsutomu Sato, MD PhD, Toshiro Kurokawa, MD PhD, Hideo Yagi, Yasushi Terasaki, MD PhD, Kinya Ohata, MD PhD, Takashi Yoshida, MD PhD, Malek Faham, MD PhD, Shinji Nakao, MD PhD

Blood (2015) 126 (23): 1788.

https://doi.org/10.1182/blood.V126.23.1788.1788

Published: 2015

Journal Articles

Long Term Efficacy, Safety and Tolerability (>24 Months) of Twice Daily Dosing of Deferasirox in Transfusion Dependent Thalassemias Who Were Unresponsive to Standard Once Daily Dose

Bunchoo Pongtanakul, MD, Vip Viprakasit, Dr.

Blood (2015) 126 (23): 958.

https://doi.org/10.1182/blood.V126.23.958.958

Published: 2015

NARROW

Thrombotic Thrombocytopenia Purpura Case Series in Skmc 2016-2017

Kidney Ultrasound Findings in Sickle Cell Anemia According to Kidney Disease and the APOL1 G1/G2 Risk Variants

The Real-World Frequency of 24-Hour Urine Protein Electrophoresis (UPEP), Serum Free Light Chain (SFLC), and Serum Protein Electrophoresis (SPEP) Testing in Patients with Multiple Myeloma (MM)

Urine Cultures at the Onset of Febrile Neutropenia (FN) in Patients with Haematological Malignancies Rarely Impact Antibiotic Management in the Absence of Urinary Symptoms

Comparison of Residual Neoplastic Plasma Cell Number Using Multicolor Flow Cytometry and Various Stages of International Myeloma Working Group-Defined Responses in Patients with Multiple Myeloma

A Case of Immunotactoid Glomerulopathy (ITG) Associated with Monoclonal B-Cell Lymphocytosis (MBL) with Chronic Lymphocytic Leukemia (CLL) Phenotype Treated with Obinutuzumab

Ambulatory Hypertension in a Pediatric Cohort of Sickle Cell Disease

Dasatinib Induced Reversible Nephrotic Range Proteinuria Occurs More Frequently Compared to Other Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia

Phase II, Multiple-Dose Study of Anti-FcRn Antibody, Rozanolixizumab (UCB7665), in Patients with Primary Immune Thrombocytopenia: Interim Analysis

SYNT001: A Humanized IgG4 Monoclonal Antibody That Disrupts the Interaction of FcRn and IgG for the Treatment of IgG-Mediated Autoimmune Diseases

Impact of Normalized Free Light Chain Ratio for Assessment of Monoclonal Protein in Patients with Light Chain Only and Oligosecretory Myeloma

Novel Mutation in CD46 in a Child with Atypical Hemolytic Uremic Syndrome (HUS) Characterized By Profound Thrombocytopenia and Anemia

Nonclinical Safety of SHP 826 (BAX 826), a Next Generation Extended Half-Life Recombinant Factor VIII Product

Establishing Sickle Cell Diagnostics and Characterizing a Pediatric Sickle Cell Disease Cohort in Malawi

Hematuria Is Not a Risk Factor for the Hypertension of Hemophilia

Multidisciplinary Evaluation Improves Efficacy and Safety of Iron Chelation Therapy with Deferasirox in MDS Elderly Patients

Screening for Occult Malignancy Following First Unprovoked VTE: A Single Centre Experience

Transition of Intensive Chemotherapy for Acute Lymphoblastic Leukemia (ALL) to the Outpatient Setting: Analysis of Safety and Cost Savings

Prognostic Value of Sequencing-Based Minimal Residual Disease Detection in Patients with Multiple Myeloma Who Underwent Autologous Stem Cell Transplantation

Long Term Efficacy, Safety and Tolerability (>24 Months) of Twice Daily Dosing of Deferasirox in Transfusion Dependent Thalassemias Who Were Unresponsive to Standard Once Daily Dose

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only